Lucentis(®) using Visudyne(®) study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration

PURPOSE: Combination verteporfin photodynamic therapy (vPDT) and antivascular endothelial growth factor (anti-VEGF) therapy may decrease the need for injections while maintaining visual acuity in exudative age-related macular degeneration. This pilot study was designed to determine the threshold flu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chen, Eric, Brown, David M, Wong, Tien P, Benz, Matthew S, Kegley, Eric, Cox, Joel, Fish, Richard H, Kim, Rosa Y
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2010
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952607/
https://ncbi.nlm.nih.gov/pubmed/20957143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S13969
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars